Detalhe da pesquisa
1.
The effect of (neo)adjuvant chemotherapy on long-term survival outcomes in patients with invasive lobular breast cancer treated with endocrine therapy: A retrospective cohort study.
Cancer
; 130(6): 927-935, 2024 03 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37985357
2.
Trastuzumab and first-line taxane chemotherapy in metastatic breast cancer patients with a HER2-negative tumor and HER2-positive circulating tumor cells: a phase II trial.
Breast Cancer Res Treat
; 205(1): 87-95, 2024 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-38291268
3.
The effect of trastuzumab on cardiac function in patients with HER2-positive metastatic breast cancer and reduced baseline left ventricular ejection fraction.
Int J Cancer
; 151(4): 616-622, 2022 08 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-35403708
4.
Heat-induced BRCA2 degradation in human tumours provides rationale for hyperthermia-PARP-inhibitor combination therapies.
Int J Hyperthermia
; 34(4): 407-414, 2018 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28705099
5.
First-Line Palliative HER2-Targeted Therapy in HER2-Positive Metastatic Breast Cancer Is Less Effective After Previous Adjuvant Trastuzumab-Based Therapy.
Oncologist
; 22(8): 901-909, 2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28533475
6.
A randomized phase 2 study exploring the role of bevacizumab and a chemotherapy-free approach in HER2-positive metastatic breast cancer: The HAT study (BOOG 2008-2003), a Dutch Breast Cancer Research Group trial.
Cancer
; 122(19): 2961-70, 2016 Oct.
Artigo
em Inglês
| MEDLINE | ID: mdl-27315546
7.
Toxicity of (neo)adjuvant chemotherapy for BRCA1- and BRCA2-associated breast cancer.
Breast Cancer Res Treat
; 156(3): 557-566, 2016 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-27060914
8.
Tumor-agnostic ctDNA levels by mFAST-SeqS in first-line HR-positive, HER2 negative metastatic breast cancer patients as a biomarker for survival.
NPJ Breast Cancer
; 9(1): 61, 2023 Jul 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-37452019
9.
Development of a Clinical Prediction Model for 1-Year Mortality in Patients With Advanced Cancer.
JAMA Netw Open
; 5(11): e2244350, 2022 11 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36449290
10.
Neutrophil-guided dosing of anthracycline-cyclophosphamide-containing chemotherapy in patients with breast cancer: a feasibility study.
Med Oncol
; 32(4): 113, 2015 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-25772511
11.
Development and validation of an UPLC-MS/MS method for the quantification of tamoxifen and its main metabolites in human scalp hair.
J Pharm Biomed Anal
; 114: 416-25, 2015 Oct 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-26119504
12.
Diagnostic and therapeutic ionizing radiation and the risk of a first and second primary breast cancer, with special attention for BRCA1 and BRCA2 mutation carriers: a critical review of the literature.
Cancer Treat Rev
; 41(2): 187-96, 2015 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-25533736
13.
Denosumab in breast cancer treatment.
Eur J Pharmacol
; 717(1-3): 12-9, 2013 Oct 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-23545361